145 related articles for article (PubMed ID: 37890653)
21. The value of high-resolution HLA in the perioperative period of non-sensitized lung transplant recipients.
Zhang J; Liu D; Zhang C; Zhou M; Lv J; Wang H; Yang H; Fan L; Wu B; Chen J
Ann Transl Med; 2020 Feb; 8(3):37. PubMed ID: 32154282
[TBL] [Abstract][Full Text] [Related]
22. More precise donor-recipient matching: the role of eplet matching.
Wiebe C; Nickerson PW
Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):630-635. PubMed ID: 32889983
[TBL] [Abstract][Full Text] [Related]
23. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
[TBL] [Abstract][Full Text] [Related]
24. [Heart transplantation. Indications, results and perspectives].
Wahlers T; Pethig K; Fieguth HG; Demertzis S; Hausen B; Mügge A; Wolpers K; Heublein B; Borst HG
Internist (Berl); 1996 Mar; 37(3):283-8. PubMed ID: 8919945
[No Abstract] [Full Text] [Related]
25. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
26. [Heart transplantation--current status and development].
Reichart B; Reichenspurner H
Internist (Berl); 1990 Oct; 31(10):641-7. PubMed ID: 2283208
[No Abstract] [Full Text] [Related]
27. Cardiac transplantation.
Pifarre R; Sullivan HJ; Montoya A; Bakhos M; Grieco J; Foy B; Blakeman B; Costanzo-Nordin MR
Cardiol Clin; 1989 Feb; 7(1):183-94. PubMed ID: 2650870
[TBL] [Abstract][Full Text] [Related]
28. Role of cardiac transplantation in the management of congestive heart failure.
Baumgartner WA
Am J Med; 1986 Feb; 80(2B):51-3. PubMed ID: 3511696
[No Abstract] [Full Text] [Related]
29. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
30. Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.
McCaughan JA; Battle RK; Singh SKS; Tikkanen JM; Moayedi Y; Ross HJ; Singer LG; Keshavjee S; Tinckam KJ
Am J Transplant; 2018 Dec; 18(12):2924-2933. PubMed ID: 29847022
[TBL] [Abstract][Full Text] [Related]
31. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
[TBL] [Abstract][Full Text] [Related]
32. [Chronic heart failure (VIII). The present and future of the heart transplant in the treatment of chronic heart failure. The role of mechanical circulatory assistance].
Alonso Pulpón L; Anguita Sánchez M; Crespo Leiro M; Segovia Cubero J
Rev Esp Cardiol; 1992 Apr; 45(4):270-83. PubMed ID: 1598465
[No Abstract] [Full Text] [Related]
33. Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software.
Tassone G; De Santis D; Vukovic I; Downing J; Martinez OP; D'Orsogna LJ
HLA; 2020 Jul; 96(1):52-63. PubMed ID: 32281731
[TBL] [Abstract][Full Text] [Related]
34. HLA-DR matching reduces rejection rate in heart transplantation.
Leivestad T; Foerster A; Simonsen S; Bratlie A; Thorsby E; Geiran O
Transpl Int; 1996; 9 Suppl 1():S230-3. PubMed ID: 8959835
[TBL] [Abstract][Full Text] [Related]
35. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
[TBL] [Abstract][Full Text] [Related]
36. Estimation of Antibody-Verified Eplet Mismatch Load, 2-Field HLA Resolution vs Imputation in a Large Cohort of European Donors.
Renuncio-García M; González-López E; Carreras E; Villa J; Romón-Alonso I; Roa-Bautista A; Gutiérrez-Larrañaga M; Comins-Boo A; Irure-Ventura J; López-Hoyos M; San Segundo D
Transplant Proc; 2022 Nov; 54(9):2414-2418. PubMed ID: 36333253
[TBL] [Abstract][Full Text] [Related]
37. [Heart transplantation].
Pavie A; Bonnet N; Leprince P; Barreda T
Rev Prat; 2007 Feb; 57(3):287-93. PubMed ID: 17578029
[TBL] [Abstract][Full Text] [Related]
38. HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details.
Tambur AR
Front Immunol; 2018; 9():2010. PubMed ID: 30233594
[TBL] [Abstract][Full Text] [Related]
39. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
[TBL] [Abstract][Full Text] [Related]
40. [Heart transplantation--state of the art today].
Meiser BM; von Scheidt W; Weis M; Böhm D; Kur F; Koglin J; Reichenspurner H; Uberfuhr P; Reichart B
Herz; 1997 Oct; 22(5):237-52. PubMed ID: 9441155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
